fulvestrant has been researched along with Disease Models, Animal in 71 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (8.45) | 18.2507 |
| 2000's | 24 (33.80) | 29.6817 |
| 2010's | 35 (49.30) | 24.3611 |
| 2020's | 6 (8.45) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Cong, H; Li, D; Liu, J; Lu, Y; Tian, W; Wei, A; Yang, L; Zhuo, Y | 1 |
| Freiberg, C; Otto, C; Ulbrich, HF | 1 |
| Aftimos, P; Arlt, H; Bardia, A; Bidard, FC; Bihani, T; Binaschi, M; Burr, R; Chirn, B; Cortés, J; Dubash, TD; Fiascarelli, A; Habboubi, N; Haber, DA; Iafrate, AJ; Kaklamani, VG; LiCausi, JA; Maheswaran, S; Patel, H; Rai, S; Reeves, BA; Scartoni, S; Toner, M; Wittner, BS | 1 |
| Cao, C; He, X; Li, H; Li, L; Wu, W; Yu, X; Zeng, Y | 1 |
| Arrighi, A; Ballestrero, A; Becherini, P; Brandhorst, S; Caffa, I; Cea, M; Cilli, M; Clevers, H; Cortellino, S; Cremonini, AL; De Braud, F; Driehuis, E; Ferrando, L; Gradaschi, R; Longo, VD; Mantero, C; Mastracci, L; Monacelli, F; Nencioni, A; Odetti, P; Passalacqua, M; Piacente, F; Piazza, S; Provenzani, A; Salvadori, G; Spagnolo, V; Sukkar, SG; Tagliafico, A; Valdemarin, F; Vellone, VG; Vernieri, C; Wei, M; Zoppoli, G; Zucal, C | 1 |
| Chang, YF; Fanning, SW; Green, B; Greene, GL; Greene, ME; Komm, B; Kurleto, JD; Lainé, M; Phung, L | 1 |
| Huang, Y; Wang, G; Wang, X; Wang, Y; Zhang, Y | 1 |
| Acosta, MC; Copley, PA; Harrell, JR; Wilhelm, JC | 1 |
| Dacic, S; Farooqui, M; Rothenberger, NJ; Siegfried, JM; Stabile, LP | 1 |
| Austin, ED; Brittain, EL; Chen, X; Farber-Eger, EH; Fessel, JP; Hemnes, AR; Loyd, JE; Talati, M; West, J | 1 |
| Chen, S; Kwon, E; Munster, PN; Park, J; Pawlowska, N; Piper, M; Sbitany, H; Terranova Barberio, M; Thomas, S | 1 |
| Benet, LZ; Krings, G; Munster, PN; Park, J; Pawlowska, N; Terranova-Barberio, M; Thomas, S; Wolfe, AR; Zhong, AY | 1 |
| Cheng, J; Jia, X; Liu, G; Shao, Z; Shen, Z | 1 |
| Deng, Y; Guo, H; Hou, W; Hou, Y; Ma, Y; Ma, Z; Qin, P; Sun, Y; Wang, S; Zhang, Z; Zou, W | 1 |
| Bénard, F; Langlois, R; Lecomte, R; Ouellet, R; Paquette, M; Phoenix, S; Turcotte, EE; van Lier, JE | 1 |
| Helgason, CD; Mager, DL; Nakamura, H; Romanish, MT; Wang, Y; Xue, H | 1 |
| Chen, W; Wu, ZY; Zhang, B; Zhang, CG; Zhou, QB | 1 |
| Bai, G; Cao, L; Gao, H; Gui, S; Lu, R; Wang, F; Zhang, Y | 1 |
| Bao, J; Chen, Y; Dai, Y; Hu, X; Li, R; Lu, Z; Qiu, W; Shu, Y; Wu, A; Xu, W | 1 |
| Hasan, DM; Hashimoto, T; Kanematsu, Y; Kitazato, KT; Kudo, M; Liang, EI; Makino, H; Murakami, S; Nagahiro, S; Pena Silva, RA; Shikata, F; Shimada, K; Tada, Y; Wada, K | 1 |
| Bi, W; Hou, W; Li, X; Shi, H; Wang, J; Wang, Y; Zhang, X | 1 |
| Liu, M; Luo, Z; Rui, F; Sun, L | 1 |
| Chen, G; Fu, S; Liao, Y; Liu, Z; Tang, H; Xu, L; Yu, L; Zhang, C; Zhou, S | 1 |
| Agin, A; Boehm, N; Charloux, A; Geny, B; Oswald-Mammosser, M; Rashid, S; Schini-Kerth, V | 1 |
| Munster, PN; Park, J; Raha, P; Thomas, S; Thurn, KT | 1 |
| Campbell, H; Davies, BR; Dowsett, M; Gao, Q; Guest, SK; Johnston, S; Liccardi, G; Marangoni, E; Martin, LA; Pancholi, S; Polanska, UM; Rani, A; Ribas, R; Simigdala, N; Thuleau, A | 1 |
| Hua, Y; Keep, RF; Xi, G; Xie, Q | 1 |
| Bonnefoi, H; Grellety, T; Iggo, R; MacGrogan, G; Richard, E; Velasco, V | 1 |
| Bernoulli, J; Lammintausta, R; Santti, R; Yatkin, E | 1 |
| Alfinito, PD; Atherton, J; Chen, X; Cosmi, S; Deecher, DC | 1 |
| Enns, DL; Tiidus, PM | 1 |
| Aloisi, AM; Ceccarelli, I; Fiorenzani, P; Pessina, F; Sgaragli, G; Valeri, A | 1 |
| Ackerman, A; Aronovitz, MJ; Baker, C; Donaldson, C; Eder, S; Hall-Porter, M; Karas, RH; Molkentin, JD; Patten, RD; Wang, F; Weiss, AD | 1 |
| Badaue-Passos, D; Gomez-Sanchez, CE; Guo, F; Hay, M; Johnson, AK; Xue, B | 1 |
| Schaub, CE; Wood, CE | 1 |
| Chung, SH; Lambert, PF | 1 |
| Chen, WF; Lai, WP; Leung, PC; Mok, SK; Wang, XL; Wong, MS; Yao, XS | 1 |
| Janahmadi, M; Javan, M; Khakpay, R; Semnanian, S | 1 |
| Danalache, B; Gangal, M; Gutkowska, J; Jankowski, M; Wang, D | 1 |
| Bagheri, M; Joghataei, MT; Mohseni, S; Roghani, M | 1 |
| Ji, Y; Tang, B; Traub, RJ | 1 |
| Arends, MJ; Charnock-Jones, DS; Cheng, CW; Cook, E; Licence, D; Luo, F; Print, CG; Smith, SK | 1 |
| Chen, YX; Dhaliwal, B; Hibbert, B; Ma, X; McNulty, M; O'Brien, E; Ramirez, D; Rayner, K; Simard, T; Sun, J | 1 |
| Liang, HC; Liu, XN; Sun, NX; Wang, YN; Xiao, XH; Zhang, HB | 1 |
| Cao, DY; Ji, Y; Tang, B; Traub, RJ | 1 |
| Bacquié, V; Bézirard, V; Houdeau, E; Moussa, L; Salvador-Cartier, C; Théodorou, V | 1 |
| Azzam, D; da Silva, T; Gilbert, CA; Hevia-Paez, P; Ince, TA; Levin, ER; Lu, Y; Mills, GB; Pedram, A; Rabinovich, B; Reis, IM; Simpkins, F; Slingerland, JM; Sun, J; Ullmer, W; Verhaak, RG; Xu, XX; Yang, JY | 1 |
| Brodie, AM; Jelovac, D; Long, BJ; Thiantanawat, A | 1 |
| McCarthy, MM; Nuñez, JL | 1 |
| Hultcrantz, M; Sahlin, L; Simonoska, R; Stenberg, AE; Stygar, D | 1 |
| Brodie, A; Goloubeva, O; Jelovac, D; Macedo, L; Sabnis, G; Tilghman, S | 1 |
| Hoff, JT; Hua, Y; Keep, RF; Nakamura, T; Park, JW; Xi, G | 1 |
| Ariazi, E; Bertucci, A; Grigg, R; Jordan, VC; Lee, ES; Meeke, K; Morris, C; O'Regan, RM; Osipo, C; Sarker, MA | 1 |
| Han, D; Lü, Q; Wang, R; Xu, J; Zhang, GY; Zhang, QG | 1 |
| Ariazi, EA; Ariazi, JL; Cordera, F; Gill, SD; Jordan, VC; Kim, HR; Lewis-Wambi, JS; Li, T; Pyle, JR; Sharma, CG; Shupp, HA | 1 |
| Guo, SW; Olive, DL | 1 |
| Aschner, M; Feustel, PJ; Kimelberg, HK; Milatovic, D; Zhang, Y | 1 |
| Booth, EA; Kilbourne, EJ; Knittel, AK; Lucchesi, BR; Marchesi, M | 1 |
| De Stefano, I; Fabrizi, M; Ferlini, C; Gallo, D; Mantuano, E; Mozzetti, S; Scambia, G | 1 |
| McClean, J; Nuñez, JL | 1 |
| Balhorn, A; Dakhama, A; Gelfand, EW; Joetham, A; Loader, JE; Matsubara, S; Miyahara, N; Ohnishi, H; Swasey, CH; Takeda, K | 1 |
| Coronado-Heinsohn, EB; Hilsenbeck, SG; Manning, DL; McClelland, RA; McCue, BL; Nicholson, RI; Osborne, CK; Wakeling, AE | 1 |
| Hardy, SP; Higgins, CF; Jacob, TJ; Valverde, MA; Zhang, JJ | 1 |
| Carver, JM; Lundeen, SG; McKean, ML; Winneker, RC | 1 |
| Chadwick, CC; Hermsmeyer, K; Minshall, RD; Miyagawa, K; Novy, MJ | 1 |
| Assikis, VJ; Bilimoria, MM; Chatterton, R; Cisneros, A; Dragan, YP; England, GM; Jordan, VC; MacGregor, JI; Muenzner, HD; O'Regan, RM; Piette, M; Pitot, HC | 1 |
| Brodie, A; Gimbel, M; Grigoryev, D; Liu, Y; Long, BJ; Lu, Q | 1 |
| Kunselman, AR; Legro, RS; Miller, SA; Satyaswaroop, PG | 1 |
| Connell, BJ; Cribb, AE; Saleh, TM | 1 |
2 review(s) available for fulvestrant and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic observations in MCF-7 aromatase xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Nitriles; Receptors, Estrogen; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2005 |
Two unsuccessful clinical trials on endometriosis and a few lessons learned.
Topics: Adult; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometriosis; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Middle Aged; Needs Assessment; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Severity of Illness Index; Species Specificity; Treatment Failure | 2007 |
69 other study(ies) available for fulvestrant and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Syringaresinol attenuates sepsis-induced cardiac dysfunction by inhibiting inflammation and pyroptosis in mice.
Topics: Animals; Cardiotonic Agents; Cinnamates; Disease Models, Animal; Fulvestrant; Furans; Heart; Heart Diseases; Humans; Indoles; Inflammation; Lignans; Male; Mice; Molecular Docking Simulation; Myocardium; Pyroptosis; Receptors, Estrogen; Sepsis; Sirtuin 1 | 2021 |
The effects of prolactin receptor blockade in a murine endometriosis interna model.
Topics: Animals; Antibodies; Disease Models, Animal; Endometriosis; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Mice; Receptors, Prolactin | 2022 |
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Models, Animal; Estrogen Antagonists; Female; Fulvestrant; Humans; Neoplastic Cells, Circulating; Receptors, Estrogen | 2023 |
Applying vibration in early postmenopausal osteoporosis promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells and suppresses postmenopausal osteoporosis progression.
Topics: Animals; Bone Density; Bone Marrow Cells; Cell Differentiation; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Disease Progression; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Gene Expression Regulation; Humans; Mesenchymal Stem Cells; Osteocalcin; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; PPAR gamma; Rats; Rats, Sprague-Dawley; Signal Transduction; Tibia; Transcription Factors; Vibration | 2019 |
Fasting-mimicking diet and hormone therapy induce breast cancer regression.
Topics: Animals; Biological Factors; Breast Neoplasms; Diet Therapy; Diet, Healthy; Disease Models, Animal; Disease Progression; Drug Resistance, Neoplasm; Early Growth Response Protein 1; Fasting; Female; Fulvestrant; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Piperazines; PTEN Phosphohydrolase; Pyridines; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Xenograft Model Antitumor Assays | 2020 |
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Models, Animal; Estrogen Receptor alpha; Female; Fulvestrant; Humans; MCF-7 Cells; Mice; Mutation; Neoplasm Metastasis; Piperazines; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Pyridines; Pyrrolidines; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Treatment Outcome | 2021 |
Inhibition of 17-beta-estradiol on neuronal excitability via enhancing GIRK1-mediated inwardly rectifying potassium currents and GIRK1 expression.
Topics: Animals; Bee Venoms; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Epilepsy; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation; Hippocampus; Membrane Potentials; Neurons; Ovariectomy; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Pregnancy; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Tetrodotoxin | 2017 |
Estrogen signaling is necessary for exercise-mediated enhancement of motoneuron participation in axon regeneration after peripheral nerve injury in mice.
Topics: Animals; Axons; Disease Models, Animal; Estradiol; Estrogen Receptor Modulators; Estrogens; Exercise Therapy; Female; Fulvestrant; Male; Mice, Inbred C57BL; Motor Activity; Motor Neurons; Nerve Regeneration; Peripheral Nerve Injuries; Random Allocation; Receptors, Estrogen; Sciatic Nerve | 2017 |
Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Benzamides; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Estradiol; Estrogens; Female; Fibroblast Growth Factors; Fulvestrant; Humans; Ligands; Lung Neoplasms; Mice; Neoplastic Stem Cells; Piperazines; Protein Binding; Pyrazoles; Receptors, Estrogen; Receptors, Fibroblast Growth Factor; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
Topics: Anastrozole; Animals; Bone Morphogenetic Protein Receptors, Type II; Disease Models, Animal; Echocardiography; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hemodynamics; Humans; Hypertension, Pulmonary; Insulin Resistance; Lung; Mice; Mice, Knockout; Mutation; Nitriles; Signal Transduction; Tamoxifen; Triazoles | 2017 |
Autologous Fat Grafting as a Novel Antiestrogen Vehicle for the Treatment of Breast Cancer.
Topics: Adipose Tissue; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cells, Cultured; Chemotherapy, Adjuvant; Disease Models, Animal; Drug Delivery Systems; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mammaplasty; Mice; Mice, Nude; Transplantation, Autologous | 2017 |
Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Chromatography, Liquid; Disease Models, Animal; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Germ-Line Mutation; Humans; Tandem Mass Spectrometry; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |
Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Drug Synergism; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Gene Expression; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Mice; Models, Biological; Signal Transduction; Xenograft Model Antitumor Assays; Zoledronic Acid | 2018 |
The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation.
Topics: Animals; Animals, Newborn; Cell Hypoxia; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Glucose; Infarction, Middle Cerebral Artery; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Microglia; Neurons; Ovariectomy; Receptors, Estrogen; Receptors, G-Protein-Coupled; Toll-Like Receptor 4 | 2018 |
Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
Topics: Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Estradiol; Female; Fulvestrant; Humans; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Receptors, Estrogen; Tissue Distribution | 2013 |
Genistein versus ICI 182, 780: an ally or enemy in metastatic progression of prostate cancer.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Disease Progression; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Gene Expression Regulation, Neoplastic; Genistein; Humans; Male; Metallothionein; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Prostatic Neoplasms; RNA, Small Interfering; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
Topics: Animals; Antioxidants; Arterioles; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Fulvestrant; Hemodynamics; Hydrogen Peroxide; Hypertension, Portal; Ligation; Mesenteric Arteries; Ovariectomy; Oxidative Stress; Portal Pressure; Portal Vein; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Superoxides; Vascular Resistance | 2013 |
Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.
Topics: Animals; Cell Line, Transformed; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Extracellular Matrix Proteins; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Indoles; Intercellular Signaling Peptides and Proteins; Maleimides; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Inbred F344; Time Factors | 2014 |
Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.
Topics: Animals; Astrocytes; Cell Movement; Cells, Cultured; Chemokine CCL20; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Estradiol; Female; Fulvestrant; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; NF-kappa B; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Signal Transduction; Th17 Cells | 2014 |
Estrogen protects against intracranial aneurysm rupture in ovariectomized mice.
Topics: Aged; Aneurysm, Ruptured; Animals; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; Humans; Intracranial Aneurysm; Mice; Mice, Inbred C57BL; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitriles; Ovariectomy; Phenols; Pyrazoles; Subarachnoid Hemorrhage | 2014 |
17β-estradiol mediates upregulation of stromal cell-derived factor-1 in the retina through activation of estrogen receptor in an ischemia-reperfusion injury model.
Topics: Animals; Blotting, Western; Chemokine CXCL12; Disease Models, Animal; Estradiol; Estrogen Receptor Antagonists; Estrogens; Fulvestrant; Gene Expression Regulation; Male; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Reperfusion Injury; Retina; RNA, Messenger; Up-Regulation | 2015 |
Icariin recovers the osteogenic differentiation and bone formation of bone marrow stromal cells from a rat model of estrogen deficiency-induced osteoporosis.
Topics: Animals; Bone Density Conservation Agents; Bone Marrow Cells; Cell Differentiation; Disease Models, Animal; Estradiol; Estrogen Receptor alpha; Female; Flavonoids; Fulvestrant; Mesenchymal Stem Cells; Osteogenesis; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Receptors, Progesterone; Up-Regulation | 2015 |
Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Agents, Hormonal; Carcinogenesis; Disease Models, Animal; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Middle Aged; Signal Transduction; Tissue Array Analysis; Urethane | 2014 |
Effect of the oestrogen receptor antagonist fulvestrant on the cirrhotic rat lung.
Topics: Animals; Cell Adhesion Molecules; Disease Models, Animal; Estradiol; Estrogen Receptor Antagonists; Fulvestrant; Heme Oxygenase (Decyclizing); Hepatopulmonary Syndrome; Liver Cirrhosis, Biliary; Lung; Macrophages; Male; Microfilament Proteins; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphoproteins; Phosphorylation; Rats, Wistar; Tyrosine; Vascular Endothelial Growth Factor A | 2015 |
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Gene Expression; Gene Expression Profiling; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Ligands; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Receptors, Estrogen; Tamoxifen; Transcription, Genetic; Transcriptome; Xenograft Model Antitumor Assays | 2015 |
AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Female; Fulvestrant; Gene Expression Profiling; Humans; Mice; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Pyrimidines; Pyrroles; Receptors, Estrogen; Signal Transduction; TOR Serine-Threonine Kinases; Transcriptional Activation; Xenograft Model Antitumor Assays | 2015 |
Effects of Gender and Estrogen Receptors on Iron-Induced Brain Edema Formation.
Topics: Animals; Brain; Brain Edema; Caudate Nucleus; Chlorides; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogen Receptor Antagonists; Female; Fulvestrant; Iron; Iron Compounds; Male; Mice; Mice, Inbred C57BL; Receptors, Estrogen; Sex Factors; Tamoxifen | 2016 |
The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours.
Topics: Animals; Antineoplastic Agents; Apocrine Glands; Breast Neoplasms; Cellular Microenvironment; Disease Models, Animal; Estradiol; Female; Fulvestrant; Heterografts; Humans; Ki-67 Antigen; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Piperazines; Pyridines; Receptor, ErbB-2; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone | 2016 |
Fispemifene [Z-2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)-phenoxy]ethoxy}-ethanol], a novel selective estrogen receptor modulator, attenuates glandular inflammation in an animal model of chronic nonbacterial prostatitis.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Estradiol; Estrogen Antagonists; Fos-Related Antigen-2; Fulvestrant; Immunohistochemistry; Male; Organ Size; Prolactin; Prostatitis; Rats; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Testosterone | 2008 |
ICI 182,780 penetrates brain and hypothalamic tissue and has functional effects in the brain after systemic dosing.
Topics: Animals; Blood-Brain Barrier; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Ethinyl Estradiol; Female; Fulvestrant; Hot Flashes; Hypothalamus; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Ovariectomy; Rats; Rats, Sprague-Dawley; Skin Temperature; Uterus | 2008 |
Point:Counterpoint: Estrogen and sex do/do not influence post-exercise indexes of muscle damage, inflammation, and repair.
Topics: Animals; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogens; Exercise; Fulvestrant; Humans; Muscle, Skeletal; Myositis; Rats; Regeneration; Sex Factors | 2009 |
Effects of 17beta-estradiol on rat urinary bladder: gender differences in anoxia-glucopenia and reperfusion damage.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Glucose; Hypoxia; In Vitro Techniques; Injections, Subcutaneous; Male; Muscle Contraction; Neuroprotective Agents; Nitriles; Rats; Rats, Wistar; Reperfusion Injury; Sex Factors; Testosterone; Time Factors; Triazoles; Urinary Bladder; Urinary Bladder Diseases | 2009 |
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Topics: Animals; Animals, Newborn; Calcineurin; Cell Size; Cells, Cultured; Disease Models, Animal; Drug Implants; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hemodynamics; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardial Contraction; Myocardium; Myocytes, Cardiac; NFATC Transcription Factors; Ovariectomy; Phenylephrine; Proteasome Endopeptidase Complex; Receptors, Estrogen; Signal Transduction; Time Factors; Ubiquitin; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension.
Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Body Weight; Brain; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypertension; Infusion Pumps, Implantable; Male; Orchiectomy; Ovariectomy; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Sex Factors; Sodium Chloride; Sympathetic Nervous System; Time Factors | 2009 |
Blockade of estrogen action upregulates estrogen receptor-alpha mRNA in the fetal brain.
Topics: Animals; Brain; Disease Models, Animal; Embryo, Mammalian; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fetal Development; Fetus; Fulvestrant; Gene Expression Regulation, Developmental; Sheep | 2009 |
Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.
Topics: Animals; Antineoplastic Agents, Hormonal; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Mice; Mice, Transgenic; Papillomavirus Infections; Raloxifene Hydrochloride; Uterine Cervical Neoplasms | 2009 |
Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.
Topics: Alkaline Phosphatase; Animals; Bone Density; Bone Density Conservation Agents; Cell Line; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Femur; Flavonoids; Fulvestrant; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoporosis; Osteoprotegerin; Ovariectomy; Phosphorylation; RANK Ligand; Rats; RNA, Messenger; Tibia; Time Factors; Tomography, X-Ray Computed; Transfection | 2010 |
The effect of intra-locus coeruleus injection of 17beta-estradiol on inflammatory pain modulation in male rat.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Bicuculline; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogens; Formaldehyde; Fulvestrant; Inflammation; Locus Coeruleus; Male; Microinjections; Pain; Rats; Rats, Sprague-Dawley; Valine | 2010 |
Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fibrosis; Fulvestrant; Genistein; Hypertension; Myocardial Contraction; Myocardium; Natriuretic Peptide, Brain; Ovariectomy; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Oxytocin; RNA, Messenger; Vasotocin; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2010 |
Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Avoidance Learning; Disease Models, Animal; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hippocampus; Infusions, Intraventricular; Male; Malondialdehyde; Maze Learning; Memory, Short-Term; Mental Recall; Microinjections; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Phytoestrogens; Random Allocation; Rats; Rats, Wistar; Retention, Psychology; Statistics, Nonparametric; Thiobarbituric Acid Reactive Substances | 2011 |
Spinal estrogen receptor alpha mediates estradiol-induced pronociception in a visceral pain model in the rat.
Topics: Afferent Pathways; Analysis of Variance; Animals; Colon; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Ginsenosides; Ovariectomy; Pain; Rats; Rats, Sprague-Dawley; Sapogenins; Spinal Cord; Viscera | 2011 |
Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis.
Topics: Animals; Disease Models, Animal; Endometriosis; Epithelial Cells; Estradiol; Estrogen Antagonists; Extracellular Matrix; Female; Fulvestrant; Genes, ras; Immunocompetence; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Receptors, Estrogen; Stromal Cells | 2011 |
Attenuation of atherogenesis via the anti-inflammatory effects of the selective estrogen receptor beta modulator 8β-VE2.
Topics: Animals; Anti-Inflammatory Agents; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Estradiol; Estrogen Receptor beta; Female; Fulvestrant; Inflammation; Interleukin-1beta; Macrophages; Mice; Mice, Knockout; Organ Size; Ovariectomy; Tumor Necrosis Factor-alpha; Uterus | 2011 |
17-Alpha-estradiol ameliorating oxygen-induced retinopathy in a murine model.
Topics: Animals; Animals, Newborn; Capillary Permeability; Dextrans; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Fluoresceins; Fulvestrant; Humans; Immunoenzyme Techniques; Infant, Newborn; Lipid Peroxidation; Malondialdehyde; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Oxygen; Retina; Retinal Vessels; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A | 2012 |
Estrogen receptor β activation is antinociceptive in a model of visceral pain in the rat.
Topics: Animals; Disease Models, Animal; Estradiol; Estrogen Receptor beta; Female; Fulvestrant; Nitriles; Nociception; Oxazoles; Phenols; Posterior Horn Cells; Propionates; Rats; Rats, Sprague-Dawley; Visceral Pain | 2012 |
A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats.
Topics: Animals; Disease Models, Animal; Estradiol; Estrogen Receptor Modulators; Feces; Female; Fermentation; Fulvestrant; Gastrointestinal Tract; Germination; Glycine max; Irritable Bowel Syndrome; Permeability; Phytoestrogens; Protease Inhibitors; Proteolysis; Rats; Rats, Wistar; Receptors, Estrogen; Seeds; Soy Foods; Stress, Physiological; Stress, Psychological | 2013 |
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzodioxoles; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Enzyme Activation; Estradiol; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Ovarian Neoplasms; Protein Binding; Protein Transport; Quinazolines; Receptors, Estrogen; src-Family Kinases; Xenograft Model Antitumor Assays | 2012 |
The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Topics: Animals; Aromatase; Aromatase Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; In Vitro Techniques; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Tamoxifen; Triazoles; Tumor Cells, Cultured | 2002 |
Estradiol exacerbates hippocampal damage in a model of preterm infant brain injury.
Topics: Animals; Animals, Newborn; Cell Death; Cells, Cultured; Disease Models, Animal; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Fulvestrant; GABA Agonists; Hippocampus; Humans; Hypoxia-Ischemia, Brain; In Vitro Techniques; Infant, Newborn; Infant, Premature; Male; Muscimol; Pregnancy; Rats; Rats, Sprague-Dawley | 2003 |
Effect of estrogen and antiestrogens on the estrogen receptor content in the cochlea of ovariectomized rats.
Topics: Animals; Cochlea; Disease Models, Animal; Down-Regulation; Estradiol; Female; Fulvestrant; Humans; Immunohistochemistry; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Stria Vascularis; Tamoxifen | 2003 |
Estrogen therapy for experimental intracerebral hemorrhage in rats.
Topics: Animals; Brain; Brain Edema; Cerebral Hemorrhage; Disease Models, Animal; Drug Administration Schedule; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Male; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Sex Factors | 2005 |
Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gefitinib; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Quinazolines; Raloxifene Hydrochloride; RNA, Messenger; Structure-Activity Relationship; Transplantation, Heterologous; Trastuzumab; Xenograft Model Antitumor Assays | 2006 |
Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats.
Topics: Animals; Blotting, Western; Chromones; Disease Models, Animal; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Hippocampus; Immunohistochemistry; Immunoprecipitation; Ischemic Attack, Transient; Male; MAP Kinase Kinase 7; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase Kinase Kinase 11; Morpholines; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Serine; Signal Transduction | 2006 |
Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Estradiol; Fulvestrant; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Selective Estrogen Receptor Modulators | 2006 |
Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.
Topics: Amidines; Analysis of Variance; Animals; Antioxidants; Disease Models, Animal; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Estradiol; Estrogen Antagonists; F2-Isoprostanes; Fulvestrant; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen | 2007 |
The pathway-selective estrogen receptor ligand WAY-169916 reduces infarct size after myocardial ischemia and reperfusion by an estrogen receptor dependent mechanism.
Topics: Animals; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Ligands; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Ovariectomy; Pyrazoles; Rabbits; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2007 |
Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Drug Synergism; Estradiol; Estrogens; Female; Fulvestrant; Glycine max; Humans; Kallikreins; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Organ Size; Phytoestrogens; Plant Extracts; RNA, Messenger; Thrombospondin 1; Uterus; Xenograft Model Antitumor Assays | 2007 |
17alpha-Estradiol is neuroprotective in male and female rats in a model of early brain injury.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Brain Injuries; Cells, Cultured; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; GABA Agonists; Hippocampus; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Male; Maze Learning; Muscimol; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sex Factors; Time Factors | 2008 |
Estrogen determines sex differences in airway responsiveness after allergen exposure.
Topics: Allergens; Animals; Bronchial Hyperreactivity; Disease Models, Animal; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Male; Methacholine Chloride; Mice; Mice, Inbred BALB C; Neurokinin A; Neurokinin-1 Receptor Antagonists; Ovalbumin; Sex Characteristics | 2008 |
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Tamoxifen | 1995 |
Lens opacification by antioestrogens: tamoxifen vs ICI 182,780.
Topics: Animals; Cataract; Cattle; Chloride Channels; Disease Models, Animal; Estradiol; Estrogen Antagonists; Fulvestrant; In Vitro Techniques; Neuroblastoma; Patch-Clamp Techniques; Tamoxifen; Tumor Cells, Cultured | 1995 |
Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels.
Topics: Animals; Cholesterol; Dexamethasone; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogens; Ethinyl Estradiol; Female; Fulvestrant; Lipids; Ovariectomy; Piperidines; Progesterone; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1997 |
In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium Signaling; Coronary Vasospasm; Coronary Vessels; Disease Models, Animal; Disease Susceptibility; Enzyme Activation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hormone Antagonists; Hormone Replacement Therapy; Humans; Macaca mulatta; Microscopy, Confocal; Microscopy, Fluorescence; Mifepristone; Muscle Proteins; Muscle, Smooth, Vascular; Ovariectomy; Postmenopause; Progesterone; Protein Kinase C; Receptors, Estrogen; Receptors, Progesterone; Serotonin; Thromboxane A2; Vasoconstriction | 1998 |
Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Models, Animal; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Mice; Mice, Nude; Ovariectomy; Tamoxifen; Toremifene | 1998 |
The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer.
Topics: Analysis of Variance; Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Disease Models, Animal; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Tamoxifen; Time Factors; Triazoles; Tumor Cells, Cultured | 1999 |
Role of androgens in the growth of endometrial carcinoma: an in vivo animal model.
Topics: Androgens; Animals; Aromatase; Blotting, Western; Carcinoma; Disease Models, Animal; Electrophoresis, Agar Gel; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Regression Analysis; Testosterone; Transplantation, Heterologous | 2001 |
Estrogen-induced recovery of autonomic function after middle cerebral artery occlusion in male rats.
Topics: Animals; Autonomic Nervous System; Baroreflex; Blood Pressure; Brain; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Heart Rate; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2001 |